High Expression of a New Marker PCA-1 in Human Prostate Carcinoma
Open Access
- 15 July 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 11 (14), 5090-5097
- https://doi.org/10.1158/1078-0432.ccr-05-0195
Abstract
Purpose: Identifying the genetic factors involved in prostate carcinogenesis is critical. Novel cancer-specific markers aid in early detection, in differentiating between cancer and nonmalignant disorders, and in monitoring clinical of prostate disease. We therefore examined differential gene displays in an attempt to identify genes that may be involved in prostate carcinogenesis. Experimental Design: Applying fluorescent differential display analysis to human prostate carcinomas, we have identified and cloned several cDNA transcripts. Antisera were raised against synthetic peptides and used in Western blot and immunohistochemical analyses. The mRNAs were also analyzed by real-time reverse transcription-PCR. For functional analysis, we assessed methylmethane sulfonate (MMS)–induced toxicity in COS-7 cells after cDNA transfection. Results: We identified a gene, designated prostate cancer antigen-1 (pca-1), which shows high mRNA expression in prostate carcinoma. Database analysis of the deduced amino acid sequence of PCA-1 indicated high similarity to Escherichia coli AlkB, a DNA alkylation damage repair enzyme. By immunohistochemical analysis, PCA-1 was expressed in a high number of both prostate carcinoma samples and in the atypical cells within high-grade prostatic intraepithelial neoplasias but not in benign prostatic hyperplasia or normal adjacent tissues. PCA-1-transfected COS-7 cells further showed resistance against MMS-induced cell death. Conclusions: These findings suggest that PCA-1 could be a useful diagnostic marker. Furthermore, because this human counterpart of AlkB exhibits a protective function against alkylation damage in mammalian cells, PCA-1 may also serve as a therapeutic target molecule for prostate cancer.Keywords
This publication has 28 references indexed in Scilit:
- MGMT: its role in cancer aetiology and cancer therapeuticsNature Reviews Cancer, 2004
- Analysing differential gene expression in cancerNature Reviews Cancer, 2003
- α-Methylacyl-CoA RacemaseThe American Journal of Surgical Pathology, 2003
- Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNANature, 2003
- A fix for RNANature, 2003
- AlkB-mediated oxidative demethylation reverses DNA damage in Escherichia coliNature, 2002
- Oxidative demethylation by Escherichia coli AlkB directly reverts DNA base damageNature, 2002
- Tazarotene-Induced Gene 1 (TIG1) Expression in Prostate Carcinomas and Its Relationship to TumorigenicityJNCI Journal of the National Cancer Institute, 2002
- Heterogeneous Methylation and Deletion Patterns of the INK4a/ARF Locus Within Prostate CarcinomasThe American Journal of Pathology, 2002
- Contribution of O6‐alkylguanine and N‐alkylpurines to the formation of sister chromatid exchanges, chromosomal aberrations, and gene mutations: New insights gained from studies of genetically engineered mammalian cell linesEnvironmental and Molecular Mutagenesis, 1993